ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.608,16
0,68%
S&P 500
5.283,40
0,11%
Dow Jones
38.571,03
-0,30%
Euro vs US Dollar
1,09014
0,45%
Bitcoin
69.113,74
2,02%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Edwards Lifesciences Corp (EW)

  7. Edwards Lifesciences Corp (EW) News

EW

Edwards Lifesciences (EW)

Edwards Lifesciences Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:EW
DatumZeitQuelleÜberschriftSymbolFirma
03/06/202412h38Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
03/06/202412h30Business WireEdwards Lifesciences to Sell Critical Care to BDNYSE:EWEdwards Lifesciences Corp
03/06/202412h30PR Newswire (US)BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology LeaderNYSE:EWEdwards Lifesciences Corp
30/05/202423h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
30/05/202422h25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
30/05/202422h08Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:EWEdwards Lifesciences Corp
21/05/202423h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
21/05/202422h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
13/05/202423h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202422h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
 Showing the most relevant articles for your search:NYSE:EW

Kürzlich von Ihnen besucht

NYSE
XOM
Exxon Mobil
COIN
SOLUSD
Solana
AMEX
SPY
SPDR S&P 500
TG
BAS
BASF
COIN
BTCUSD
Bitcoin
FX
EURJPY
Euro vs Yen
NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
TG
432
Arbor Metals
TG
DBK
Deutsche Bank
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten